The office management of hypertension.
D000328:Adult; D001741:Black or African American; D000367:Age Factors; D000553:Ambulatory Care; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001581:Benzothiadiazines; D001794:Blood Pressure / Q000187:drug effects; D004232:Diuretics; D005260:Female; D006145:Guanethidine / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000175:diagnosis / Q000628:therapy*; D008297:Male; D008750:Methyldopa / Q000627:therapeutic use; D009765:Obesity / Q000150:complications; D009887:Ophthalmoscopy; D010353:Patient Education as Topic; D011331:Private Practice; D011433:Propranolol / Q000627:therapeutic use; D012110:Reserpine / Q000627:therapeutic use; D012737:Sex Factors; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D000959:Antihypertensive Agents; D001581:Benzothiadiazines; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors; D014665:Vasodilator Agents; D008750:Methyldopa; D012110:Reserpine; D011433:Propranolol; D006145:Guanethidine